The global Separation Systems for Commercial Biotechnology market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Separation Systems for Commercial Biotechnology volume and value at global level, regional level and company level. From a global perspective, this report represents overall Separation Systems for Commercial Biotechnology market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Separation Systems for Commercial Biotechnology in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Separation Systems for Commercial Biotechnology manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Thermo Fisher Scientific
GE Healthcare
Agilent Technologies;Shimadzu Corporation
bioMérieux SA
Bio-Rad Laboratories, Inc.
Hitachi Koki Co., Ltd.
Merck & Co., Inc.
QIAGEN
WATERS
Sartorius
PerkinElmer, Inc.
Danaher
Miltenyi Biotec
BD

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Microarray
Lab-on-a-chip
Biochip
Magnetic separation
Chromatography
Flow cytometry
Membrane filtration
Electrophoresis
Centrifugation

Segment by Application
Pharmaceutical
Food & Cosmetics
Agriculture
Others